PDCD1 and neoplasm: Similarly, Zhang et al. [20] performed scRNA-seq on peripheral T cells from patients with NSCLC before and after PD-1 blockade and found that tumor-related CD4+ T cell clones exhibited higher cytotoxicity than controls.